C2Dx Inc. and Quintree Partner to Distribute Telemedicine Platform

C2Dx Inc. in Kalamazoo, a medical device company that invests in and refines the delivery of valuable niche products to propel their growth and accessibility, has partnered with Quintree in Detroit, a telemedicine platform that integrates with existing diagnostic equipment.
8
A laptop and smartphone showing Quintree's telemedicine platform.
C2Dx Inc. will be the exclusive provider of Detroit-based Quintree’s telemedicine platform that integrates with all diagnostic equipment. // Courtesy of Quintree

C2Dx Inc. in Kalamazoo, a medical device company that invests in and refines the delivery of valuable niche products to propel their growth and accessibility, has partnered with Quintree in Detroit, a telemedicine platform that integrates with existing diagnostic equipment.

Quintree was created by Dr. Adam Folbe and Sandy Kronenberg with the mission to drive higher efficiencies and standards-of-care for patients through a seamless connection between medical providers and specialists.

Folbe experienced first-hand how much some doctors have to run from hospital to hospital to scope and assess patients and had an idea to create a platform where he could remotely see through a diagnostic scope in real time. This has evolved into a technology with broad application across medical specialties, particularly when using a scope or intraoperative camera for diagnosis and to guide medical procedures.

Quintree works when a provider — from an ER, office, or urgent care — initiates a session with a specialist. From there, the provider scopes the patient, transmitting real time audio and video that the specialist can view in real time to provide consultation and complete an interpretation report that is then sent back to the provider.

It is HIPPA compliant, allows for real time image capturing and notes, does not require onsite servers or hardware, integrates with all existing platforms, requires no capital expense, and is installed quickly.

C2DX will be the exclusive provider of this technology, its third product offering since its establishment in 2019. The partnership is expected to broaden the availability of the specialist network and minimize time to diagnosis.

“We can unleash the full benefits of telemedicine to reduce physician burden and broaden reach,” says Kevin McLeod, CEO of C2Dx. “We are thrilled to have Quintree as another tool that we are able to provide in order to break down the barriers of care for those in need.”

Facebook Comments